33 results
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
?
The timing of a special meeting to consider the Share Issuance Proposal required for the completion of the Acquisition would have occurred around the time
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
unrelated to the Acquisition?
The timing of a special meeting to consider the Share Issuance Proposal required for the completion of the Acquisition would
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
to be voted on at the special meeting. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PRELIMINARY AND DEFINITIVE … on at the special meeting. Information about the Company’s directors and executive officers is included in the Company’s most recent definitive proxy statement
8-K
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
on at the special meeting. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PRELIMINARY AND DEFINITIVE PROXY STATEMENTS, ANY … of the Aggregate Consideration in the Acquisition and the PIPE Shares in the Private Placement and any other matters to be voted on at the special meeting. Information
8-K
EX-99.2
wxvke2o3xa4xhapj
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-99.1
n2wp5rjwu8fn2ss
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
10-K
EX-4.3
rtux0h5
7 Mar 22
Annual report
4:03pm
10-K
p5mwty xtr9ire
7 Mar 22
Annual report
4:03pm
10-Q
glv0y5dv5wk2o
13 Sep 21
Quarterly report
4:01pm
8-K
EX-3.1
9l07ddhz7 52
12 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:25pm